downloadGroupGroupnoun_press release_995423_000000 copyGroupnoun_Feed_96767_000000Group 19noun_pictures_1817522_000000Member company iconResource item iconStore item iconGroup 19Group 19noun_Photo_2085192_000000 Copynoun_presentation_2096081_000000Group 19Group Copy 7noun_webinar_692730_000000Path
Skip to main content
Default Banner Image

Smart MedTech

As healthcare undergoes a digital transformation, semiconductor technologies are emerging as a critical foundational enabler, making care more personalized, proactive, and accessible. At SEMI, we’re proud to highlight the leadership of STMicroelectronics (ST), a member and active participant in our Smart MedTech initiative’s governing council, for their commitment to advancing this critical frontier.With decades of experience in sensing, power management, and connectivity, ST is helping to shape a future where electronic systems seamlessly integrate with healthcare and wellness solutions, empowering both patients and providers.The Rise of Wearables and the Role of SemiconductorsST has long delivered innovation in automotive, industrial, and consumer electronics. Now, the company is applying its expertise to wearable health technologies, a rapidly growing segment that’s reshaping how we monitor, diagnose, and manage health.Today’s wearables go far beyond their predecessors. They capture vital signs and biomarkers such as heart rate variability, ECG signals, blood pressure trends, and more with medical-grade accuracy, providing real-time insights that can inform treatment and improve outcomes. This evolution represents not just a technological leap, but a shift in how we deliver and think about healthcare.A Shared Mission to Scale MedTech InnovationST’s active engagement with SEMI’s Smart MedTech initiative reflects our shared commitment to building an agile, responsive ecosystem that can bring life-changing technologies to the market faster. Through Smart MedTech, SEMI unites leaders across the electronics and healthcare value chains to identify systemic barriers, spark cross-sector dialogue, and co-create strategies for scalable success.ST brings invaluable perspective and technical depth to this mission. Their approach focusing on full solutions rather than standalone components, demonstrates how semiconductor companies can play a central role in enabling integrated healthcare systems.Meeting the Moment: Prevention, Personalization, and ReachHealthcare systems globally face mounting challenges: aging populations, chronic disease burdens, rising costs, and a projected shortfall of 18 million healthcare workers (WHO, 2019). Against this backdrop, wearables and remote health monitoring tools are poised to deliver tremendous value.As ST points out, the economic case is clear: treating chronic disease can be 100 times more expensive than prevention, wearables offer a proactive path forward. By enabling continuous, at-home health tracking, these devices empower individuals to take control of their wellness and allow providers to intervene earlier and more effectively.Accelerating the Future TogetherAt the SEMI 2025 Technology Workshop, ST joined a panel discussion exploring how semiconductors are reshaping healthcare. The session highlighted the need for earlier diagnosis, personalized care, and scalable solutions amid rising chronic disease and healthcare labor shortages.Panelists emphasized moving beyond component sales to integrated, system-level solutions. ST’s role on the Smart MedTech governing council emphasizes their commitment to cross-sector collaboration and advancing MedTech adoption.The MedTech revolution requires more than great products, it demands aligned ecosystems, shared knowledge, and coordinated strategies. As a member of SEMI and a key voice in our Smart MedTech initiative, ST exemplifies how semiconductor innovation can drive real change in healthcare.We’re proud to work alongside ST and other industry leaders who are committed to creating smarter, more sustainable healthcare through electronics. Because in today’s healthcare landscape, an ounce of prevention enabled by semiconductors isn’t just worth a pound of cure, it’s a blueprint for global health resilience.See the full ST article STMicroelectronics and Medtech: Enabling Personalized Healthcare and Wellness through the Integration of Electronics featured on Smart MedTech webpage.Gity Samadi is Senior Director of R D at SEMI.Rafael Tudela Senior Technical Marketing Manager at SEMI.Michelle Smith-Moritz is Senior Program Manager, Smart MedTech at SEMI.
Read More
Taking aim at advancing smart medtech innovation, the SEMI Nano-Bio Materials Consortium (NBMC), in collaboration with the U.S. Air Force Research Laboratory (AFRL), in March 2020 identified 12 organizations from industry and academia as recipients of $20.4 million in funding, leveraging $10.7 million of cost-share from award recipients. Unique to this round – the sixth in NBMC’s eight years – is a pilot program for NBMC and AFRL to collaborate more closely and share more resources. As part of that effort, AFRL is contributing additional funding to seven of the 12 projects to enable its researchers to work alongside industry on the projects in the new AFRL-Industry Co-Development Program. After being matched to a project during pre-RFP discussions – also known as the White Paper Stage – AFRL researchers were designated as NBMC Consortium Project Investigators before collaborating with industry on the second stage of proposal development. Once contract negotiations between NBMC and the proposing entity wrap up, the AFRL investigators will participate in the development of smart medtech innovations. “This is a new way for AFRL researchers to participate as project performers responsible for contributing to project milestones and deliverables, in addition to providing program management oversight that AFRL has employed for past NBMC projects,” said Dr. Jeremy Ward, past NBMC government lead and current participant in the AFRL Entrepreneurial Opportunity Program. “This program should enable technical risk-reduction for industry by leveraging AFRL competencies and U.S. Air Force aeromedical and airmen performance mission connectedness and ultimately help speed the development of dual-use smart medtech,” added Matt Dalton, AFRL Materials and Manufacturing Directorate program manager and NBMC Governing Council member. “We need efficient mechanisms to leverage research being done outside of AFRL,” said Sharma, who is also senior technical lead for Cognitive Neuroscience at AFRL's 711th Human Performance Wing. “If someone is developing a groundbreaking technology that can be helpful for our airmen, then let’s work with them so that we have an opportunity at an early stage to actively shape that research for Air Force-relevant use cases. Similarly, with this co-development initiative, external researchers will also get an opportunity to work alongside world-class researchers at AFRL and, through those interactions, get insights into the needs of the operational community.” “The AFRL-Industry Co-Development Program strengthens the work between AFRL and industry to better target the strategic needs of the Air Force for dual-use technologies while more closely aligning with commercial market requirements,” said Dr. Melissa Grupen-Shemansky, SEMI CTO and Executive Director of NBMC. “This new collaboration will enable the growth of the ecosystem critical to bringing the latest smart medtech innovations to market while making the technology’s supply chain more sustainable and resilient.” SEMI NBMC connects military, industry and academia for research and development into the practical use of nano-biomaterials. The 2020 RFP targeted nano-bio materials for wearables, flexible and alternative power sources for wearables, and open concepts for wearables for diagnostics and ambulatory monitoring. These technologies address the critical need to monitor, evaluate and mitigate stress experienced by workers in high-pressure occupations – such as aviation, emergency, critical care and aeromedical evacuation – to enhance their warfighter performance and help ensure their well-being. For more information on SEMI NBMC, our R D funding projects, and how you can help shape the direction of our funding programs, visit our website or contact me at [email protected]. Learn more about our projects at the 2021 Global Smart MedTech Symposium July 28-29 and August 4-5, 2021. For more information about the NBMC-AFRL collaboration, see the 2020 Smart MedTech Virtual Workshop agenda. This article borrows from a U.S. Air Force press release on May 27, 2021. Rene Krantz is program manager for SEMI NBMC Smart MedTech.
Read More
If you bought a new car recently, you must have noticed that it warns you if one of its functions needs your attention. It even alerts the factory if repairs or major adjustments are needed. Wouldn’t it be nice to have similar capabilities for our bodies that will call for a “service” before we end up in an emergency room – or worse? The United States invests almost 18 percent of its Gross Domestic Product (GDP) in healthcare. Such a significant part of our economy deserves our industry’s attention – and it gets it. SEMI’s recent Smart MedTech webinar series tells not only patients and healthcare providers how electronic products can impact their lives, but also offers device makers plenty of ideas for developing new solutions.SEMI Gets SmartIn addition to working on many important topics with more than 2,200 member companies across the semiconductor supply chain, SEMI focuses on special areas: Smart Mobility (as covered here), Smart MedTech (covered below), Smart Manufacturing, and Smart Data. Smart MedTech was the topic of four recent webinars, organized by Melissa Grupen-Shemansky, executive director Nano-Bio Materials Consortium (NBMC), and Chief Technology Officer, SEMI. NBMC’s mission is to enable flexible, wearable human performance monitoring. In her introduction, she emphasized that healthcare will shift from today’s provider-centric approach to a personalized care model, with the following characteristics: Outcome-based Decentralized, not limited to geographies Specific to your personal health and medical needs With a team of providers, connected like never before To achieve all these characteristics, microelectronics will be an essential contributor. That is why SEMI and member companies are working on platforms to fund and commercialize R D as well as to educate potential users and beneficiaries. Grupen-Shemansky engaged a series of experts and organized four webinars to address this broad and complex field, and outline their contributions to meeting the above criteria. They have been recorded and are available to SEMI members. Call your SEMI contacts to find out where and how you can access slides and recordings of more than a dozen presentations.From Biomarkers to BioChemical Sensors Physiological RelevancyTo monitor a human body’s performance, researchers have to first understand which biomarkers indicate specific conditions of the body, then learn how to capture and process the data. Grupen-Shemansky moderated this August 5th session. Christina Davis from UC Davis, Jennifer Martin, and Sean Harshman from the Air Force Research Lab (AFRL), and Kenneth Ward from Pacific Diabetes Technologies presented their ongoing efforts in this field.Davis talked about the challenges of analyzing exhaled breath, which contains 99% water and 1% biomarkers. She showed a hand-held analyzer her team has developed (Figure 1). She also elaborated on how to interpret the captured data and, if needed, decide which follow-up treatments are advised.Figure 1: Palm-sized µCON exhaled breath micro-condenser used to analyze biomarkers. (Courtesy: UC Davis) AFRL’s Martin and Harshman outlined how ongoing and future minimally invasive techniques are being used to monitor airmen, and give them advice for self-treatment to maximize their performance. The Pacific Diabetes Technologies speaker, Ward, showed how to use minimally invasive, subcutaneous (=under the skin) oxygen sensors to detect hemorrhage (= blood loss) and control it.En Route Care (ERC) and Point of Care (POC) DiagnosticsTreating injuries right away and correctly shortens not only a patient’s suffering, but also improves his or her chances for a full recovery. AFRL’s Matthew Dalton moderated this August 12th session. Derek M. Sorensen from AFRL, Zheng Yan from the University of Missouri-Columbia, Melinda Eaton from the Virtual Health Program Management Office at the U.S. Department of Defense (DoD), and Azar Alizadeh from General Electric (GE) Research outlined their contributions to achieving instant and professional care.AFRL’s Sorensen described the many challenges a Critical Care Air Transport Team (CCATT) deals with when performing their work inside a noisy, dark, hot, or cold, shaking airplane, discussed their equipment and personnel constraints, and explained how difficult it is, even for experienced doctors, to perform emergency surgeries under these conditions.Professor Yan takes low cost very seriously and demonstrated how he and his students have developed on-skin wearable sensors that can be manufactured by using only pencil and paper.Eaton outlined the DoD’s strategy for assuring its medical force is ready to support soldiers. Then she discussed a broad range of the DoD’s traditional health management responsibilities and added that Covid-19 is now an important factor.Alizadeh addressed how GE microelectronic solutions improve the efficiency of care, reduce medical errors and length of hospital stays as well as improve workflows of caregivers. In addition to GE’s well-known, large/stationary medical equipment and communications infrastructure (Figure 2), Alizadeh showed that GE is also providing skin patches and other wearable sensors to capture data.Figure 2: The Future of Monitoring: In 2017, Mercy Hospital served 800,000 patients with telemedicine including those with chronic diseases. Patient:doctor ratio: US average 300:1. Mercy = 1100:1. (Courtesy: GE) Human Wearables Enabling Rapid Decision Making in the Integrated Care ContinuumAs Figure 2 above shows, microelectronic equipment can improve patient care and efficiency of medical personnel, but only if sufficient data can be captured timely and accurately – increasing the importance of wearables. AFRL’s Jeremy Ward moderated this August 17th session. Christopher Scully from the U.S. Food and Drug Administration (FDA), Ashleigh Coker from the AFRL’s Sensors Directorate, Ted Harmer from the AFRL’s Airman Systems Directorate, and AFRL’s Regina Shia presented for Oxana Pantchenko from NextFlex how they develop wearables jointly. Scully introduced the FDA’s organization and its responsibilities, described the high-value accurate data can provide, warned about the damage false alarms and equipment failures can cause, and explained the regulatory role the FDA plays in this context.AFRL’s Coker highlighted the essential role sensors play in modern warfare with several examples, described her directorate’s operations and showed their warfighter-centric design process (Figure 3).Figure 3: Warfighter-centric design process steps and the need to engage multiple heads/perspectives in this process. (Courtesy of AFRL) AFRL’s Harmer addressed the importance of good communications architecture and protocols to capture and compute data to assure efficient cooperation between land/air/sea/space-based forces.NextFlex’ Pantchenko prepared a presentation about standards-compliant wearable electroencephalography (EEG), electromyography (EMG), and electrooculography (EOG) devices, jointly developed with AFRL and several other companies. It was delivered by AFRL’s Regina Shia.Automation, Augmentation and AINatalie Wisniewski, Founder of Profusa, Inc. a and consultant in Wearables and Digital Health, moderated the fourth webinar, held on August 26. She emphasized SEMI’s role in this context, then introduced the speakers: Michael Kirby from Colorado State University, Kevin Zhao from Harmonize Health, Mary Clare McCorry from armi/biofab USA, and Andreas Caduff from ETH Zuerich.Professor Kirby outlined several mathematical principles that need to be applied to get meaningful results when analyzing data. He emphasized that genetic factors influence if an individual is susceptible, tolerant, or even resistant to certain pathogens and warned that bacteria can develop resistance to today’s antibiotics.Zhao from Harmonize talked about the importance of predictive analytics in remote care, how to filter out false alarms, and how to deliver the best available care cost-effectively. In closing, he emphasized that computers and algorithms are not replacing clinical staff.McCorry outlined how biofab USA, a program of armi, uses sensors and automation to grow replacement tissue and organs (Figure 4). She explained how they use engineering principles and life sciences to make guide cells grow into replacement tissue. The company’s plan is to expand the currently lab-based capabilities into an industrial scale tissue foundry.Figure 4: Growing ear cartilage in the lab. (Courtesy: armi/biolab USA) SummaryMcCorry summarized her presentation, and actually the entire webinar series, with these statements: The human body is a 3D, highly complex, dynamic, and multi-faceted biological construct Skin lends itself well as an interface between body and wearable sensors Connecting physiology (e.g. vital signs), behavior, and external factors is important for getting good results Verification, validation, and FDA involvement are important for making methods and devices successful Sensors, communication computing (AI/ML) are complementing, not replacing, medical personnel Today’s methods and devices will be outperformed by tomorrow’s solutions – stay up to date Personal CommentsSummarizing eight hours of presentations in a few pages requires a very high and lossy compression factor – please understand. I suggest you call on your SEMI contact to get access to these previous and following webinar recordings. Excellent contacts across the electronics supply chain enable SEMI to win experts in many areas to convey valuable information in these webinars.I am impressed that the USA military, specifically the AFRL, invests so much effort in medical support for airmen/women. They demonstrate that only healthy and fit personnel can take full advantage of the sophisticated weapon systems at their disposal if/when they are called upon to deploy them.This Smart MedTech webinar series confirms what many medical experts told me during exams and/or before and after surgeries: The human body is a masterpiece of bioengineering. These webinars also reminded me of what I learned at a brain-health class at Stanford University: Our brains only need about 20 Watts to perform computing and memory tasks that fairly quickly approximate the results of today’s computers – a benchmark for computer architects and AI/ML experts.Republished with permission from 3D InCites.
Read More
Innovations in the public sector are springboards for new products in digital health and personalized medicine. Since 2013, SEMI NBMC, funded by the Air Force Research Laboratory (AFRL), has been evaluating industry needs and soliciting proposals for new research into the foundations of device development and manufacturing of medically actionable devices.SEMI NBMC has run 17 separate programs with more than two dozen organizational participants developing materials, electronics, microfluidics, manufacturing processes and algorithms to create low-cost, wearable sensors. Most of these integrated sensing systems communicate wirelessly and incorporate high-performance silicon devices that are designed to move with the individual. Each of the projects was the result of a proposal received during NBMC’s annual proposal cycle. ​What’s Next in MedTech Device Development?We invite you to join the teams at SEMI, NBMC and AFRL to answer that question in a virtual series of sessions over the four weeks in August.For the past five years, NBMC has been conducting similar sessions for roadmapping the development of non-invasive human performance monitoring technology and manufacturing. The information feeds into the topics for upcoming RFPs, including the one we expect to release in September 2020. Previous Workshops (formerly entitled Blood Sweat and Tears) brought together industry and university innovators to explore current product research and provided excellent insights for the proposal evaluation teams. We believe the insights are also very useful to the business and technology planning direction for researchers and developers working on these products.Our focus is on early-adopting markets – medical professionals and their patients, Army and Air Force personnel and high-performance athletes.​ In this time of social-distancing and overall hesitancy to approach hospitals and medical offices, medical monitoring that provides medically-actionable intelligence is of even greater significance.But Doesn’t FitBitTM Have that Covered?Advancements are coming fast and furious – but medical professionals and insurance companies are struggling to distinguish innovations that provide actionable intelligence from those that provide generalized, non-actionable data.The workshop will focus on the medically relevant information that requires a great deal more accuracy, testing and certification before decisions are made. It is the innovations in this field that will lay the groundwork for new products in digital health and personalized medicine. Additionally, they are leading to advancements in aeromedical monitoring and diagnostics to support the U.S. Air Force’s mission to improve patient care during emergency air transport. The targeted future state is real-time monitoring of biochemical and physiological markers that can guide optimization of human performance and health. ​The SMART MedTech Virtual Workshop Series will link markets with manufacturing for medical relevancy – addressing both ends of the ecosystem. This forum will bring together the players across the growing range of industries that are entering or advancing human monitoring applications to:​ share competitive ideas that may be applied to product development​, assess roadblocks in bringing human monitoring products to market, and form partnerships that have become key in overcoming obstacles to successful manufacturing and product development. ​ Join the experts who are at the cutting edge of product design and manufacturing techniques. Indeed, the success of previous workshops was based on the unique membership of NBMC, where product and manufacturing-oriented engineers from industry, universities, and government labs form teams and pool resources (financial as well as technical) to accelerate human monitoring product development into manufacturing prototypes.Can’t Attend the Workshop?All sessions will be recorded and available for watching and re-watching on-demand. Join our interest list to receive regular updates on SEMI NBMC activities, including notification of the RFP expected to be available in October 2020.Find out more about the Smart MedTech Initiative and the NBMC Programs at our website.Rene Krantz is Director of R D Programs Business Development at SEMI. She is the primary manager of SEMI Smart MedTech Initiative and NBMC programs. Contact Rene at [email protected].
Read More
Thanks to developments in science and technology, artificial intelligence (AI), cloud computing, big data and other technologies have been used to establish smart healthcare systems that helps societies respond more effectively to disease outbreaks. The spread of novel coronavirus starting in late 2019 has revealed how not only traditional medicine but also Smart MedTech applications can be instrumental on the anti-epidemic front lines.To give updates on the development of Smart MedTech and how it shines during the fight against COVID-19, SEMI invited Dr. Pei-Yuan Lee, Honorary Superintendent of Show Chwan Memorial Hospital, to share with MSIG (MEMS Sensors Industry Group) and Flex-Tech members how the international community and Taiwan are bringing their best in Smart MedTech to the table and how their collective efforts are helping tackle COVID-19 challenges.Taiwan’s COVID-19 rapid screening reagents and antibody testing help curb coronavirus transmissions Taiwan’s medical community has demonstrated its prowess in responding to the COVID-19 outbreak. Using its nucleic acid extraction reagent, Taiwan Advanced Nanotech Inc. tested 128 specimens from passengers aboard the SuperStar Aquarius cruise ship in only eight hours in early February. Taiwan’s leading research institute Academia Sinica successfully synthesized the first group of monoclonal antibodies capable of recognizing the new coronavirus protein on March 8, enabling testing to be completed in 15 minutes. The College of Medicine of National Taiwan University announced on March 27 that its 30-second screening device had helped identify asymptomatic carriers. The devices detect COVID-19 in people with no symptoms if they have pulmonary infiltration and edema. It took only 14 days for Academia Sinica to successfully synthesized the first group of monoclonal antibodies capable of recognizing the new coronavirus protein. On April 22, three biomedical companies in Taiwan launched a COVID-19 test that produces results from samples of patient mucus in less than 10 minutes to greatly enhance testing speed. Once the test method is approved by the Taiwan government, it will take Taiwan’s medical strategy against COVID-19 to the next level.Artificial Intelligence: the key to upgrading traditional healthcare practicesAI is a key enabler of the transition from traditional medical practice to Smart MedTech. To help fight the COVID-19 outbreak, a National Cheng Kung University medical team developed a 30-minute coronavirus testing procedure that uses AI to read pulmonary X-ray images and automate medical records. Taiwan AI Labs leveraged AI to simulate how drug molecules combine with viruses to reduce research time by three to four years. AI ​​diagnostic technology from the Alibaba DAMO Academy (Academy for Discovery, Adventure, Momentum and Outlook) and Alibaba Cloud interprets CT images of COVID-19 patients with 96 percent accuracy in 20 seconds. AI-powered algorithms improve diagnostic test accuracy, allowing clinicians to quickly analyze scans of pulmonary lesions and quantify the severity of lung damage.Startups have also joined the fight against COVID-19. Taiwan's Internet of Things (IoT) startup iWEECARE invented the world's smallest smart thermometer patch. Heroic-Faith Medical Science launched a device that uses IoT and AI to monitor lung sounds. With Smart MedTech expected to be fertile ground for future venture investments, enterprises must find their niches in establishing new technologies in a much more systemic way. Taiwan startup Health-Faith Medical Science developed a respiratory diagnostics device that uses IoT and AI technology to monitor chest sounds in real time. Anti-epidemic technology to help fulfill smart medtech vision Many AI and big data technologies previously deployed in hospitals and healthcare systems are helping regions around the world speed their pandemic response. The United States and China have started to develop facial mask recognition systems powered by AI, while a team in the Department of Bioinformatics and Medical Engineering at Asia University has devised a facial recognition system combining IoT and AI technology with infrared thermal imaging cameras. At Johns Hopkins University, the Center for Systems Science and Engineering is using AI to create big data models that track global cases, people and traffic flow, and other variables for real-time data analysis that enables epidemiologists to more accurately predict COVID-19 transmission paths. Graphen, Inc., a New York-based provider of next-generation AI platforms, launched the world's first AI COVID-19 genetic evolutionary path analysis systems to gauge the virus’s transmission route and accelerate pandemic response. Both the United States and China are also using robots and drones to improve epidemic research and patient treatment. For the first confirmed case in the United States, robots were used to assist with medical care. In China, robots facilitate deliveries of disinfectants to makeshift hospitals built to expand the nation’s capacity to treat COVID-19 patients. While Taiwan’s robots are traditionally used for hospitality, transportation and disinfection purposes, future robotics research and development will focus more on medical applications that shift more work from medical staff to technology. With abundant technological resources and expertise, Taiwan can join hands with the rest of the world to combat the COVID-19 pandemic. Emerging technologies are pointing the way toward a new paradigm for healthcare community. Biotech, artificial intelligence, and robotics have given rise to new applications that increase virus screening accuracy and efficiency. This growing wave of technological defenses against the pandemic will become a long-term force for stability and strength in healthcare systems across the world.To get involved in SEMI Taiwan Smart MedTech Community, please contact Helen Chen, Outreach Manager, at [email protected] Huang and Winnie Chang are marketing and public relations specialists at SEMI Taiwan.
Read More
“A hundred years from now, someone’s going to look back and say, ‘Can you believe they waited until you got a disease, and then they did something?’” This observation from Dr. William Hait, the leader of Johnson Johnson’s External Innovation program, crisply sums up the SEMI Smart MedTech Summit, a two-day program at SEMICON Europa 2019, sponsored by GE Research and imecBenjamin Wiegand, PhD of Johnson Johnson, cited the quote in his opening presentation and added another pertinent question: “What if we could predict who was going to get a disease and then preempt it from happening?” Weigand’s conclusion is the first of six key takeaways from the summit.1. Accomplishing this vision could lead to a world without disease. Developing a disease-free world by exploring how the integration of advanced electronics and medical technology (MedTech) can enable new healthcare solutions is the very mission of the SEMI Smart MedTech Initiative. Various experts speaking at the MedTech Summit delved into a range of topics, from pan-European medical initiatives and artificial organs to new sensors and systems and start-ups’ need for funding and partners.2. All of us will have a digital twin (avatar), bringing together all relevant data that can impact our health and well-being.Several speakers illustrated the advantages of a digital human avatar that would start with an individual’s unique physical data and then be continuously updated with new data tracked by body-worn devices and from ongoing research findings. This would enable healthcare providers to extract insights and predict future physical performance or health issues.While, technologically, the avatar can already be constructed, the ability to make real changes to future human behavior is a significant outstanding question. Multiple speakers highlighted the various benefits of digital avatars at the MedTech Summit. 3. The MedTech sector’s need for cybersecurity looms large, as it does in every other digitally-driven, IOT-based framework.Further exploring the human-to-digital interface, Anthony Mathur of Bart’s Heart Center in the UK pointed to the importance of strict laws for safeguarding patient privacy, a cornerstone of healthcare digital policies, and the critical need for cybersecurity. He warned against an all-digital action network, citing the virus attack that shut down the UK’s National Health Service, rendering all patient records inaccessible for more than two weeks.4. MedTech devices, systems and other tools will radically change healthcare in the not-too-distant future.Almost every speaker touched on this point, including Franz Laermer of Bosch in his presentation The Future of Personalized Treatment. Laermer explored devices that will drive more patient-centric healthcare in areas including asthma therapy and molecular diagnostic testing and highlighted innovations in monitoring oncology therapies more effectively, less invasively and more accurately. Other presenters showcased their work in areas including silicon-based microfluidics, next-generation DNA sequencing and synthesis, lab-on-chip and cell arrays. 5. Startups and well-established companies will help advance digital tools and data to keep us healthier, happier and safer. Among the MedTech Summit highlights, several start-ups presented their business, financial and go-to-market plans. Notably, continuous glucose monitoring (CGM) is an especially active area of investment and innovation, as diabetes is among the world’s most widespread chronic diseases. The industry’s goal is to develop a non-invasive platform as a replacement for today’s prick-and-test approach to measuring blood sugar levels.6. Pan-European organizations are working to coordinate efforts and investments in digital healthcare. The European healthcare sector is large and diverse, as shown in the following slide provided by the organization MedTech Europe. Every country has its own legal framework, infrastructure, and health service structure medical technology companies must navigate. More than 27,000 medtech companies are located in Europe – 95% of them small to medium size businesses. Michael Stubin and Patrick Boisseau from MedTech Europe said concerted efforts to coordinate research and structural changes across the EU are underway to help spur medtech innovation and, with healthcare accounting for 10% of Europe's GDP, drive more market opportunity. This table shared by MedTech Europe points to the wide range of medical systems by country across the continent. Next StepsIs your company applying microelectronics innovations to change the way we approach medical care? If so, you’re invited to share your mission, roadmap and collaboration needs at a future MedTech Initiative Forum. For regular updates, join the MedTech interest list. In addition to the SEMI MedTech Initiative, our Nano-Bio Materials Consortium (NBMC) brings together scientists, engineers and business development professionals from industry, government and universities to collaboratively initiate research and development of electronic technologies to improve human performance monitoring and performance augmentation. Find out more at www.semi.org/collaborate/communities/NBMC.Michael Ciesinski is the Vice President of Technology Communities at SEMI.
Read More